Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
CARDIOTHORACIC	O
Allergies:	O
Penicillins	O
/	O
Morphine	O
/	O
Sulfur	O
/	O
Hydrochlorothiazide	O
/	O
Lipitor	O
/	O
simvastatin	O
Attending:	O
___	O
Chief	O
Complaint:	O
shortness	O
of	O
breath	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
___	O
Coronary	O
Artery	O
Bypass	O
surgery	O
(LIMA-LAD,SVG-RPDA,SVG-OM1,	O
SVG-OM2)	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
year	O
old	O
female	O
status	O
post	O
coronary	O
artery	O
bypass	O
grafting	O
with	O
Dr.	O
___	O
on	O
___.	O
Her	O
post-operative	O
course	O
was	O
complicated	O
by	O
atrial	O
fibrillation	O
but	O
was	O
otherwise	O
uneventful.	O
She	O
was	O
transferred	O
from	O
the	O
intensive	O
care	O
unit	O
to	O
___	O
6	O
post-operative	O
day	O
three,	O
and	O
then	O
transferred	O
to	O
___	O
___	O
in	O
___,	O
___	O
rehab	O
on	O
post-operative	O
day	O
six.	O
Several	O
calls	O
have	O
been	O
received	O
from	O
the	O
rehab	O
reporting	O
the	O
___	O
complaint	O
of	O
shortness	O
of	O
breath	O
although	O
room	O
air	O
sats	O
have	O
been	O
>95%.	O
She	O
reportedly	O
has	O
been	O
afebrile	O
with	O
a	O
normal	O
white	O
blood	O
cell	O
count.	O
The	O
facility	O
reports	O
persistant	O
shortness	O
of	O
breath	O
now	O
with	O
irregular	O
tachycardia.	O
Past	O
Medical	O
History:	O
coronary	O
artery	O
bypass	O
grafting	O
___,	O
coronary	O
artery	O
disease	O
(LAD	O
stent	O
___	O
yrs	O
ago,	O
three	O
RCA	O
and	O
PDA	O
stents	O
___,	O
NSTEMI	O
___,	O
myocardial	O
infarction	O
___,	O
mild	O
aortic	O
stenosis	O
___	O
1.2-1.9	O
cm2),	O
poorly	O
controlled	O
diabetes	O
(last	O
HbA1C	O
7.5%),	O
dyslipidemia,	O
hypertension,	O
cerebral	O
vascular	O
accident,	O
___	O
acute	O
left	O
posterior	O
communicating	O
artery	O
infarct,	O
atrial	O
fibrillation	O
(___	O
___,	O
spinal	O
stenosis,	O
s/p	O
hysterectomy	O
for	O
fibroids	O
Social	O
History:	O
___	O
Family	O
History:	O
-	O
Mother:	O
had	O
few	O
MIs,	O
died	O
of	O
MI	O
at	O
age	O
___	O
-	O
Father:	O
had	O
emphysema	O
-	O
Mother's	O
brother:	O
died	O
of	O
MI	O
at	O
age	O
___	O
Physical	O
Exam:	O
Readmission	O
Physical	O
Exam:	O
Pulse:	O
100	O
Resp:	O
20	O
O2	O
sat:	O
94%	O
2	O
liters	O
NC	O
B/P	O
Right:	O
130/60	O
Left:	O
Height:	O
Weight:	O
General:	O
Skin:	O
Dry	O
[x]	O
intact	O
[x]	O
HEENT:	O
PERRLA	O
[x]	O
EOMI	O
[x]	O
Neck:	O
Supple	O
[x]	O
Full	O
ROM	O
[x]	O
Chest:	O
Lungs	O
:	O
bibasilar	O
rales	O
and	O
wheezing,	O
sternal	O
wound	O
C/D/I,	O
sternum	O
stable.	O
Heart:	O
RRR	O
[]	O
Irregular	O
[x]	O
Murmur	O
[]	O
grade	O
______	O
Abdomen:	O
Soft	O
[x]	O
non-distended	O
[x]	O
non-tender	O
[x]	O
bowel	O
sounds	O
+	O
[x]	O
Extremities:	O
Warm	O
[x],	O
well-perfused	O
[x]	O
Edema	O
[x]	O
_2+	O
pitting	O
edema	O
bilat	O
___	O
Varicosities:	O
None	O
[x]	O
Neuro:	O
Grossly	O
intact	O
[x]	O
Pulses:	O
Femoral	O
Right:	O
2+	O
Left:	O
2+	O
DP	O
Right:	O
1+	O
Left:	O
1+	O
___	O
Right:	O
1+	O
Left:	O
1+	O
Radial	O
Right:	O
2+	O
Left:	O
2+	O
Carotid	O
Bruit	O
Right:	O
no	O
Left:	O
no	O
Pertinent	O
Results:	O
___	O
06:40AM	O
BLOOD	O
WBC-10.9	O
RBC-4.53	O
Hgb-11.7*	O
Hct-36.2	O
MCV-80*	O
MCH-25.8*	O
MCHC-32.3	O
RDW-16.1*	O
Plt	O
___	O
___	O
09:55PM	O
BLOOD	O
WBC-11.2*	O
RBC-3.74*	O
Hgb-9.9*	O
Hct-30.3*	O
MCV-81*	O
MCH-26.5*	O
MCHC-32.7	O
RDW-16.5*	O
Plt	O
___	O
___	O
06:20AM	O
BLOOD	O
___	O
___	O
09:55PM	O
BLOOD	O
___	O
PTT-34.8	O
___	O
___	O
06:20AM	O
BLOOD	O
Glucose-76	O
UreaN-29*	O
Creat-1.1	O
Na-138	O
K-3.8	O
Cl-96	O
HCO3-36*	O
AnGap-10	O
___	O
09:55PM	O
BLOOD	O
Glucose-168*	O
UreaN-29*	O
Creat-1.1	O
Na-135	O
K-3.8	O
Cl-93*	O
HCO3-33*	O
AnGap-13	O
___	O
07:30AM	O
BLOOD	O
ALT-57*	O
AST-41*	O
LD(LDH)-249	O
AlkPhos-99	O
Amylase-76	O
TotBili-0.6	O
___	O
ECHOCARDIOGRAPHY	O
REPORT	O
___	O
___	O
MRN:	O
___	O
Portable	O
TTE	O
(Complete)	O
Done	O
___	O
at	O
8:58:04	O
AM	O
FINAL	O
Referring	O
Physician	O
___	O
___	O
of	O
Cardiothoracic	O
Surg	O
___	O
___	O
Status:	O
Inpatient	O
DOB:	O
___	O
Age	O
(years):	O
___	O
F	O
Hgt	O
(in):	O
61	O
BP	O
(mm	O
Hg):	O
137/87	O
Wgt	O
(lb):	O
176	O
HR	O
(bpm):	O
100	O
BSA	O
(m2):	O
1.79	O
m2	O
Indication:	O
Tamponade.	O
?pericardial	O
effusion.	O
ICD-9	O
Codes:	O
427.31,	O
441.2,	O
423.9,	O
424.1,	O
424.0,	O
424.2	O
___	O
Information	O
Date/Time:	O
___	O
at	O
08:58	O
___	O
MD:	O
___.	O
___,	O
MD	O
___	O
Type:	O
Portable	O
TTE	O
(Complete)	O
Sonographer:	O
___	O
___,	O
___	O
Doppler:	O
Full	O
Doppler	O
and	O
color	O
Doppler	O
___	O
Location:	O
___	O
6	O
Contrast:	O
None	O
Tech	O
Quality:	O
Suboptimal	O
Tape	O
#:	O
___-0:00	O
Machine:	O
___	O
Echocardiographic	O
Measurements	O
Results	O
Measurements	O
Normal	O
Range	O
Left	O
Atrium	O
-	O
Long	O
Axis	O
Dimension:	O
3.9	O
cm	O
<=	O
4.0	O
cm	O
Left	O
Atrium	O
-	O
Four	O
Chamber	O
Length:	O
*5.9	O
cm	O
<=	O
5.2	O
cm	O
Right	O
Atrium	O
-	O
Four	O
Chamber	O
Length:	O
4.9	O
cm	O
<=	O
5.0	O
cm	O
Left	O
Ventricle	O
-	O
Septal	O
Wall	O
Thickness:	O
1.1	O
cm	O
0.6	O
-	O
1.1	O
cm	O
Left	O
Ventricle	O
-	O
Inferolateral	O
Thickness:	O
1.1	O
cm	O
0.6	O
-	O
1.1	O
cm	O
Left	O
Ventricle	O
-	O
Diastolic	O
Dimension:	O
4.3	O
cm	O
<=	O
5.6	O
cm	O
Left	O
Ventricle	O
-	O
Ejection	O
Fraction:	O
45%	O
>=	O
55%	O
Left	O
Ventricle	O
-	O
Stroke	O
Volume:	O
72	O
ml/beat	O
Left	O
Ventricle	O
-	O
Cardiac	O
Output:	O
7.23	O
L/min	O
Left	O
Ventricle	O
-	O
Cardiac	O
Index:	O
4.04	O
>=	O
2.0	O
L/min/M2	O
Aorta	O
-	O
Sinus	O
Level:	O
3.0	O
cm	O
<=	O
3.6	O
cm	O
Aorta	O
-	O
Ascending:	O
*3.9	O
cm	O
<=	O
3.4	O
cm	O
Aorta	O
-	O
Arch:	O
2.9	O
cm	O
<=	O
3.0	O
cm	O
Aortic	O
Valve	O
-	O
Peak	O
Velocity:	O
*2.1	O
m/sec	O
<=	O
2.0	O
m/sec	O
Aortic	O
Valve	O
-	O
Peak	O
Gradient:	O
19	O
mm	O
Hg	O
<	O
20	O
mm	O
Hg	O
Aortic	O
Valve	O
-	O
Mean	O
Gradient:	O
9	O
mm	O
Hg	O
Aortic	O
Valve	O
-	O
LVOT	O
VTI:	O
23	O
Aortic	O
Valve	O
-	O
LVOT	O
diam:	O
2.0	O
cm	O
Mitral	O
Valve	O
-	O
E	O
Wave:	O
1.1	O
m/sec	O
Mitral	O
Valve	O
-	O
E	O
Wave	O
deceleration	O
time:	O
154	O
ms	O
140-250	O
ms	O
TR	O
Gradient	O
(+	O
RA	O
=	O
PASP):	O
*32	O
mm	O
Hg	O
<=	O
25	O
mm	O
Hg	O
Findings	O
This	O
study	O
was	O
compared	O
to	O
the	O
prior	O
study	O
of	O
___.	O
LEFT	O
ATRIUM:	O
Elongated	O
LA.	O
RIGHT	O
ATRIUM/INTERATRIAL	O
SEPTUM:	O
Normal	O
RA	O
size.	O
LEFT	O
VENTRICLE:	O
Normal	O
LV	O
wall	O
thickness	O
and	O
cavity	O
size.	O
Mild	O
regional	O
LV	O
systolic	O
dysfunction.	O
Mildly	O
depressed	O
LVEF.	O
No	O
resting	O
LVOT	O
gradient.	O
RIGHT	O
VENTRICLE:	O
Normal	O
RV	O
chamber	O
size	O
and	O
free	O
wall	O
motion.	O
AORTA:	O
Normal	O
aortic	O
diameter	O
at	O
the	O
sinus	O
level.	O
Focal	O
calcifications	O
in	O
aortic	O
root.	O
Mildly	O
dilated	O
ascending	O
aorta.	O
Normal	O
aortic	O
arch	O
diameter.	O
Normal	O
descending	O
aorta	O
diameter.	O
No	O
2D	O
or	O
Doppler	O
evidence	O
of	O
distal	O
arch	O
coarctation.	O
AORTIC	O
VALVE:	O
Moderately	O
thickened	O
aortic	O
valve	O
leaflets.	O
Aortic	O
valve	O
not	O
well	O
seen.	O
Minimal	O
AS.	O
Trace	O
AR.	O
MITRAL	O
VALVE:	O
Mildly	O
thickened	O
mitral	O
valve	O
leaflets.	O
No	O
MVP.	O
Moderate	O
mitral	O
annular	O
calcification.	O
Mild	O
to	O
moderate	O
(___)	O
MR.	O
[Due	O
to	O
acoustic	O
shadowing,	O
the	O
severity	O
of	O
MR	O
may	O
be	O
significantly	O
UNDERestimated.]	O
TRICUSPID	O
VALVE:	O
Tricuspid	O
valve	O
not	O
well	O
visualized.	O
Moderate	O
[2+]	O
TR.	O
Mild	O
PA	O
systolic	O
hypertension.	O
PULMONIC	O
VALVE/PULMONARY	O
ARTERY:	O
Pulmonic	O
valve	O
not	O
visualized.	O
No	O
PS.	O
Physiologic	O
PR.	O
PERICARDIUM:	O
Trivial/physiologic	O
pericardial	O
effusion.	O
GENERAL	O
COMMENTS:	O
Suboptimal	O
image	O
quality	O
-	O
poor	O
subcostal	O
views.	O
Resting	O
tachycardia	O
(HR>100bpm).	O
The	O
rhythm	O
appears	O
to	O
be	O
atrial	O
fibrillation.	O
Left	O
pleural	O
effusion.	O
REGIONAL	O
LEFT	O
VENTRICULAR	O
WALL	O
MOTION:	O
N	O
=	O
Normal,	O
H	O
=	O
Hypokinetic,	O
A	O
=	O
Akinetic,	O
D	O
=	O
Dyskinetic	O
Conclusions	O
The	O
left	O
atrium	O
is	O
elongated.	O
Left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal.	O
There	O
is	O
mild	O
regional	O
left	O
ventricular	O
systolic	O
dysfunction	O
with	O
hypokensis	O
of	O
the	O
basal	O
inferior	O
and	O
the	O
distal	O
half	O
of	O
the	O
suptum	O
and	O
apex.	O
Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
mildly	O
depressed	O
(LVEF=	O
45%).	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
ascending	O
aorta	O
is	O
mildly	O
dilated.	O
The	O
aortic	O
valve	O
leaflets	O
are	O
moderately	O
thickened.	O
There	O
is	O
minimal	O
aortic	O
valve	O
stenosis.	O
Trace	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
Moderate	O
(2+)	O
mitral	O
regurgitation	O
is	O
seen.	O
[Due	O
to	O
acoustic	O
shadowing,	O
the	O
severity	O
of	O
mitral	O
regurgitation	O
may	O
be	O
significantly	O
UNDERestimated.]	O
Moderate	O
[2+]	O
tricuspid	O
regurgitation	O
is	O
seen.	O
There	O
is	O
mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
a	O
trivial/physiologic	O
pericardial	O
effusion.	O
IMPRESSION:	O
Normal	O
left	O
ventricular	O
cavity	O
size	O
with	O
regional	O
systolic	O
dysfunction	O
c/w	O
multivessel	O
CAD.	O
Moderate	O
mitral	O
regurgitation.	O
Minimal	O
aortic	O
stenosis.	O
Mild	O
pulmonary	O
hypertension.	O
No	O
significant	O
pericardial	O
effsusion.	O
Compared	O
with	O
the	O
prior	O
study	O
(images	O
reviewed)	O
of	O
___,	O
regional	O
left	O
ventricular	O
dysfunction	O
is	O
new	O
and	O
c/w	O
interim	O
ischemia/infarction.	O
The	O
severity	O
of	O
mitral	O
regurgitation,	O
tricuspid	O
regurgitation,	O
and	O
PA	O
systolic	O
hypertension	O
are	O
now	O
higher.	O
CLINICAL	O
IMPLICATIONS:	O
The	O
___	O
has	O
mild	O
aortic	O
valve	O
stenosis.	O
Based	O
on	O
___	O
ACC/AHA	O
Valvular	O
Heart	O
Disease	O
Guidelines,	O
a	O
follow-up	O
echocardiogram	O
is	O
suggested	O
in	O
___	O
years.	O
Based	O
on	O
___	O
AHA	O
endocarditis	O
prophylaxis	O
recommendations,	O
the	O
echo	O
findings	O
indicate	O
prophylaxis	O
is	O
NOT	O
recommended.	O
Clinical	O
decisions	O
regarding	O
the	O
need	O
for	O
prophylaxis	O
should	O
be	O
based	O
on	O
clinical	O
and	O
echocardiographic	O
data.	O
Electronically	O
signed	O
by	O
___,	O
MD,	O
Interpreting	O
physician	O
___	O
___	O
10:56	O
©	O
___	O
___.	O
All	O
rights	O
reserved.	O
Brief	O
Hospital	O
Course:	O
___	O
year	O
old	O
female	O
s/p	O
CABG	O
w/Dr	O
___	O
on	O
___.	O
Post-op	O
course	O
complicated	O
by	O
atrial	O
fibrillation,	O
otherwise	O
uneventful.	O
She	O
transferred	O
to	O
rehab	O
on	O
POD6,	O
___	O
House	O
in	O
___,	O
___.	O
Have	O
had	O
several	O
calls	O
from	O
rehab	O
reporting	O
___	O
c/o	O
SOB	O
although	O
room	O
air	O
sats	O
have	O
been	O
>95%,	O
___	O
reportedly	O
afebrile	O
with	O
normal	O
WBC.	O
Facility	O
reports	O
persistant	O
SOB	O
now	O
with	O
irreg	O
tachycardia.	O
___	O
was	O
transferred	O
to	O
___	O
for	O
further	O
care.	O
She	O
was	O
admitted	O
to	O
___	O
and	O
underwent	O
cardiac	O
transthoracic	O
echocardiogram	O
that	O
revealed	O
Normal	O
left	O
ventricular	O
cavity	O
size	O
with	O
regional	O
systolic	O
dysfunction	O
c/w	O
multivessel	O
CAD.	O
Moderate	O
mitral	O
regurgitation.	O
Minimal	O
aortic	O
stenosis.	O
Mild	O
pulmonary	O
hypertension.	O
No	O
significant	O
pericardial	O
effsusion.She	O
was	O
diuresed	O
with	O
IV	O
Lasix	O
and	O
placed	O
on	O
nebulizer	O
treatments	O
for	O
her	O
shortness	O
of	O
___	O
CXr	O
showed	O
decreasing	O
bilateral	O
pleural	O
effusions.	O
She	O
continued	O
on	O
her	O
Coumadin	O
for	O
atrial	O
fibrillation.	O
A	O
14	O
day	O
course	O
of	O
antibiotics	O
secondary	O
to	O
sternal	O
drainage	O
and	O
lower	O
extremity	O
cellulitis	O
will	O
be	O
completed	O
on	O
___.	O
Her	O
clinical	O
condition	O
slowly	O
improved	O
and	O
she	O
was	O
cleared	O
for	O
discharge	O
back	O
to	O
___	O
___	O
on	O
HD#	O
5.	O
All	O
follow	O
up	O
appointments	O
were	O
advised.	O
Medications	O
on	O
Admission:	O
Medications	O
at	O
transfer:	O
1.	O
aspirin	O
81	O
___	O
2.	O
ranitidine	O
HCl	O
150	O
mg	O
___	O
3.	O
rosuvastatin	O
5	O
mg	O
___	O
4.	O
glipizide	O
5	O
mg	O
twice	O
a	O
day.	O
5.	O
tramadol	O
50	O
mg	O
every	O
___	O
hours	O
as	O
needed	O
for	O
pain.	O
6.	O
docusate	O
sodium	O
100	O
mg	O
BID	O
7.	O
diltiazem	O
HCl	O
30	O
mg	O
QID	O
8.	O
metoprolol	O
50	O
mg	O
PO	O
TID	O
9.	O
hydralazine	O
25	O
mg	O
Q6H	O
hold	O
for	O
sbp	O
<	O
110.	O
10.	O
furosemide	O
40	O
mg	O
BID	O
11.	O
potassium	O
chloride	O
20	O
mEq	O
___	O
12.	O
RISS	O
13.	O
warfarin	O
2.5	O
___	O
14.	O
albuterol	O
nebs	O
QID	O
PRN	O
15.	O
azythromycin	O
500	O
mg	O
PO	O
___	O
Discharge	O
Medications:	O
1.	O
aspirin	O
81	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
One	O
(1)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
___.	O
2.	O
ranitidine	O
HCl	O
150	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
___	O
(___).	O
3.	O
rosuvastatin	O
5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
___	O
(___).	O
4.	O
glipizide	O
5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
5.	O
tramadol	O
50	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
Q4H	O
(every	O
4	O
hours)	O
as	O
needed	O
for	O
pain.	O
6.	O
docusate	O
sodium	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
7.	O
hydralazine	O
25	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
Q6H	O
(every	O
6	O
hours).	O
8.	O
warfarin	O
1	O
mg	O
Tablet	O
Sig:	O
___	O
per	O
MD	O
___	O
PO	O
___	O
at	O
4	O
___.	O
9.	O
insulin	O
lispro	O
100	O
unit/mL	O
Solution	O
Sig:	O
One	O
(1)	O
Subcutaneous	O
ASDIR	O
(AS	O
DIRECTED):	O
per	O
SS.	O
10.	O
magnesium	O
hydroxide	O
400	O
mg/5	O
mL	O
Suspension	O
Sig:	O
Thirty	O
(30)	O
ML	O
PO	O
Q6H	O
(every	O
6	O
hours)	O
as	O
needed	O
for	O
constipation.	O
11.	O
azithromycin	O
250	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
___	O
(___):	O
last	O
dose=	O
___.	O
12.	O
diltiazem	O
HCl	O
60	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
QID	O
(4	O
times	O
a	O
day).	O
13.	O
bisacodyl	O
10	O
mg	O
Suppository	O
Sig:	O
One	O
(1)	O
Suppository	O
Rectal	O
___	O
as	O
needed	O
for	O
constipation.	O
14.	O
metoprolol	O
tartrate	O
50	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
TID	O
(3	O
times	O
a	O
day).	O
15.	O
acetaminophen	O
325	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
Q6H	O
(every	O
6	O
hours)	O
as	O
needed	O
for	O
headache.	O
16.	O
ipratropium-albuterol	O
___	O
mcg/Actuation	O
Aerosol	O
Sig:	O
Two	O
(2)	O
Puff	O
Inhalation	O
Q6H	O
(every	O
6	O
hours).	O
17.	O
albuterol	O
sulfate	O
2.5	O
mg	O
/3	O
mL	O
(0.083	O
%)	O
Solution	O
for	O
Nebulization	O
Sig:	O
One	O
(1)	O
Inhalation	O
Q2H	O
(every	O
2	O
hours)	O
as	O
needed	O
for	O
sob/wheezing.	O
18.	O
warfarin	O
2	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
ONCE	O
(Once)	O
for	O
1	O
doses.	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
___	O
Diagnosis:	O
Coronary	O
artery	O
disease	O
(LAD	O
stent	O
___	O
yrs	O
ago,three	O
RCA	O
and	O
PDA	O
stents	O
___	O
Myocardial	O
infarction	O
___	O
NSTEMI	O
___	O
mild	O
aortic	O
stenosis	O
___	O
1.2-1.9	O
cm2)	O
poorly	O
controlled	O
Diabetes	O
(last	O
HbA1C	O
7.5%)	O
Dyslipidemia	O
Hypertension	O
CVA,	O
___	O
Acute	O
left	O
PCA	O
infarct	O
Atrial	O
fibrillation	O
(___	O
___	O
Pradaxa	O
Spinal	O
stenosis	O
Discharge	O
Condition:	O
Alert	O
and	O
oriented	O
x3	O
nonfocal	O
Ambulating	O
with	O
steady	O
gait	O
Incisional	O
pain	O
managed	O
with	O
oral	O
analgesia	O
Incisions:	O
Sternal	O
-	O
healing	O
well,	O
no	O
erythema	O
or	O
drainage	O
Leg	O
Right/Left	O
-	O
healing	O
well,	O
no	O
erythema	O
or	O
drainage.	O
Discharge	O
Instructions:	O
1)	O
Please	O
shower	O
___	O
including	O
washing	O
incisions	O
gently	O
with	O
mild	O
soap,	O
no	O
baths	O
or	O
swimming	O
until	O
cleared	O
by	O
surgeon.	O
Look	O
at	O
your	O
incisions	O
___	O
for	O
redness	O
or	O
drainage.	O
2)	O
Please	O
NO	O
lotions,	O
cream,	O
powder,	O
or	O
ointments	O
to	O
incisions.	O
3)	O
Each	O
morning	O
you	O
should	O
weigh	O
yourself	O
and	O
then	O
in	O
the	O
evening	O
take	O
your	O
temperature,	O
these	O
should	O
be	O
written	O
down	O
on	O
the	O
chart	O
provided.	O
4)	O
No	O
driving	O
for	O
approximately	O
one	O
month	O
and	O
while	O
taking	O
narcotics.	O
Driving	O
will	O
be	O
discussed	O
at	O
follow	O
up	O
appointment	O
with	O
surgeon	O
when	O
you	O
will	O
likely	O
be	O
cleared	O
to	O
drive.	O
5)	O
No	O
lifting	O
more	O
than	O
10	O
pounds	O
for	O
10	O
weeks	O
*Females:	O
Please	O
wear	O
bra	O
to	O
reduce	O
pulling	O
on	O
incision,	O
avoid	O
rubbing	O
on	O
lower	O
edge	O
**Please	O
call	O
cardiac	O
surgery	O
office	O
with	O
any	O
questions	O
or	O
concerns	O
___.	O
Answering	O
service	O
will	O
contact	O
on	O
call	O
person	O
during	O
off	O
hours**	O
Followup	O
Instructions:	O
___	O

